Source comparison
BPC-157 for Golfer's Elbow: Comparison of Administration Methods
Subcutaneous (near injury site) High localized, low systemic Daily or every 48 hours Low. Standard insulin syringe technique Most animal studies use this route Preferred method for tendon injuries. Achieves sustained local exposure without systemic distributio
This comparison does not assign a generated winner or score.
- Subcutaneous (near injury site)
- High localized, low systemic
- Daily or every 48 hours
- Low. Standard insulin syringe technique
- Most animal studies use this route
- Preferred method for tendon injuries. Achieves sustained local exposure without systemic distribution
- Intramuscular (distant site)
- Moderate systemic, variable local
- Every 48–72 hours
- Low
- Limited tendon-specific studies
- Less targeted. Relies on systemic circulation to reach injury site, which negates localized mechanism advantage
- Oral administration
- Minimal. Gastric degradation reduces bioavailability
- Daily
- None
- Gastric protection studies only
- Not supported for musculoskeletal injury. Peptide structure degrades before absorption
- Intra-articular (joint injection)
- Highest at joint structures, minimal tendon penetration
- Weekly
- High. Requires sterile technique and anatomical precision
- Not standard in published protocols
- Unnecessary for golfer's elbow. Tendon injury is extra-articular, and joint injection increases infection risk
- Subcutaneous administration 1–2 cm from the medial epicondyle delivers the highest localized tissue concentrations with the lowest systemic exposure. This mirrors the methodology used in animal studies showing accelerated tendon healing and matches the mechanism of action. BPC-157 works at the tissue level, not systemically.